According to this classification there is a fourth molecular subtype of breast cancer which does not express ER and HER2 that is named triple-negative breast cancer (TNBC); this classification helps physicians select the best chemotherapy treatment depending on the cellular phenotype. Here, ESR1 is linked to breast carcinoma.